Blue Earth

Exact Imaging

This company develops high-resolution micro-ultrasound systems for urologists to perform real-time imaging and guided biopsies for prostate cancer detection.

Full-Life Technologies

This company develops radiopharmaceuticals and radionuclide drug conjugates to treat cancer patients through targeted alpha therapy.

Alpha-9 Theranostics

This clinical-stage biotechnology company develops targeted radiopharmaceuticals to treat cancer patients by delivering radiation directly to tumours while sparing healthy tissue.

Ariceum Therapeutics

This clinical-stage biotechnology company develops targeted radiopharmaceutical therapies for the diagnosis and treatment of aggressive, hard-to-treat cancers.

Alpha-9

Alpha-9 Oncology develops targeted radiopharmaceuticals and imaging compounds for the treatment of patients with various types of cancer.

Alzeca Biosciences

This company develops MRI contrast agents to enable early diagnosis of Alzheimer's disease and other neurodegenerative disorders for healthcare providers and clinical researchers.

Ravada Health

This company develops artificial intelligence and hardware to transform MRI scanners into non-invasive pathology platforms for biopsy-saving prostate cancer diagnostics.

Biobot Surgical

This company develops robotic needle guidance systems and image fusion software for hospitals and clinics to perform prostate cancer diagnosis and treatment.